Biolidics Limited (SGX: 8YY)

Biolidics Balance Sheet

Financials in millions SGD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	0.15	0.18	5.03	3.96	10.67	6.03
Cash & Short-Term Investments	0.15	0.18	5.03	3.96	10.67	6.03
Cash Growth	-94.66%	-96.36%	26.99%	-62.88%	76.95%	-47.56%
Accounts Receivable	0.01	0.07	0.52	0.13	0.2	0.22
Other Receivables	0.07	0.03	0.13	0.19	0.09	0.06
Receivables	0.08	0.1	0.64	0.31	0.3	0.28
Inventory	-	0.01	0.03	1.51	1.61	0.9
Prepaid Expenses	0.06	0.08	0.18	0.29	0.27	0.39
Other Current Assets	0.18	0.05	0.04	0.04	0.1	0.11
Total Current Assets	0.46	0.43	5.92	6.11	12.95	7.72
Property, Plant & Equipment	0.08	0.25	0.17	1.19	1.41	1.34
Goodwill	-	-	-	0.63	0.63	-
Other Intangible Assets	-	-	-	3.5	3.78	0.57
Total Assets	0.55	0.68	6.09	11.42	18.76	9.62
Accounts Payable	0.02	0.02	0.09	0.09	0.14	0.52
Accrued Expenses	-	0.31	0.83	0.55	0.51	0.33
Current Portion of Long-Term Debt	0.98	1.08	1.05	1.02	0.87	-
Current Portion of Leases	0.09	0.2	0.21	0.25	0.26	0.14
Current Unearned Revenue	0.07	0.09	0.2	0.13	0.23	0.14
Other Current Liabilities	1.57	0.22	3.63	0.38	0.27	0.29
Total Current Liabilities	2.73	1.92	6.01	2.42	2.29	1.42
Long-Term Debt	0.18	0.61	1.69	2.74	3.76	-
Long-Term Leases	0.02	0.13	0.06	0.23	0.38	0.4
Long-Term Unearned Revenue	-	-	-	-	-	0.03
Long-Term Deferred Tax Liabilities	-	-	-	0.48	0.53	-
Other Long-Term Liabilities	-	0.01	0.02	3.22	3.52	0
Total Liabilities	2.93	2.67	7.78	9.09	10.48	1.86
Common Stock	67.52	66.54	64.36	58.88	58.33	53.8
Retained Earnings	-70	-68.55	-66.06	-56.69	-50.7	-46.05
Comprensive Income & Other	0.09	0.02	0.01	0.13	0.64	0.02
Total Common Equity	-2.39	-1.99	-1.69	2.33	8.27	7.77
Shareholders' Equity	-2.39	-1.99	-1.69	2.33	8.27	7.77
Total Liabilities & Equity	0.55	0.68	6.09	11.42	18.76	9.62
Total Debt	1.27	2.02	3.01	4.25	5.28	0.54
Net Cash (Debt)	-1.12	-1.84	2.02	-0.29	5.39	5.49
Net Cash Growth	-	-	-	-	-1.81%	-52.23%
Net Cash Per Share	-0.00	-0.00	0.01	-0.00	0.02	0.02
Filing Date Shares Outstanding	744.76	744.76	559.13	265.45	264.05	242.5
Total Common Shares Outstanding	744.76	657.63	493.37	265.45	264.05	242.5
Working Capital	-2.27	-1.49	-0.09	3.69	10.65	6.3
Book Value Per Share	-0.00	-0.00	-0.00	0.01	0.03	0.03
Tangible Book Value	-2.39	-1.99	-1.69	-1.79	3.87	7.2
Tangible Book Value Per Share	-0.00	-0.00	-0.00	-0.01	0.01	0.03
Machinery	-	2.97	2.97	3.05	2.82	2.66

Source: S&P Capital IQ. Standard template. Financial Sources.